Mutations in SOX9 cause campomelic dysplasia (CD), a dominant skeletal dysmorphology and XY sex reversal syndrome. The CD phenotype is sensitive to dosage and expression levels of SOX9. Sox9 is expressed during chondrocyte differentiation and is up-regulated in male and down-regulated in female genital ridges during sex differentiation. In order to study the sexand tissue-specific regulation of Sox9, we have defined the transcription start site and characterized the mouse Sox9 promoter region. The Sox9 proximal promoter shows moderately high nucleotide similarity between mouse and human. Transient transfection experiments using various deletion constructs of the 6.8 kb upstream region of mouse Sox9 fused to a luciferase reporter showed that the interval between 193 and 73 bp from the transcription start site is essential for maximal promoter activity in cell lines and in primary male and female gonadal somatic cells and liver cells isolated from 13.5 d.p.c. mouse embryos. This minimal promoter region was shown by DNase I hypersensitive site assay to be in an 'open' state of chromatin structure in gonads of both sexes, but not in the liver. Promoter activity was higher in testis than in ovary and liver, but deletion of the region from -193 to -73 bp abolished this difference. We conclude that the proximal promoter region is in part responsible for the sexand tissue-specific expression of the Sox9 gene and that more distal positive and negative elements contribute to its regulation in vivo, consistent with the observation that translocations upstream from SOX9 can result in campomelic dysplasia.
INTRODUCTION
The Sox9 gene encodes a transcription factor that is critical for chondrogenesis and testis determination in vertebrates. Mutations in human SOX9 cause campomelic dysplasia (CD) (1,2), a disorder characterized primarily by defects of the skeleton, but also affecting the development of the testes, kidneys, heart and brain. Sox9 is expressed in mesenchymal condensations prior to and during chondrogenesis (3) and has been shown to activate Col2a1, the gene encoding type II collagen, the major component of the cartilage matrix (4,5). More recently, SOX9 has been shown to regulate the genes encoding aggrecan (6) and type XI collagen (7) and may also regulate other structural and/or patterning genes involved in cartilage and bone development.
Male to female sex reversal is found in ∼75% of XY CD patients, indicating an additional role for Sox9 in the testisdetermining pathway. Sox9 is more highly expressed in male than female genital ridges in mouse, chicken and turtle embryos, suggesting that Sox9 is a fundamental sex-determining gene common to all vertebrates (8-10). The timing and sexually dimorphic expression indicates that Sox9 is downstream from Sry in mammals, but expression in chick and turtle gonads must be independent of Sry, which is lacking in these species. Furthermore, the expression of Sox9 in chondrogenic condensations and in the central nervous system, notochord and kidney in mouse embryos (3, 8) implicates multiple positive or negative pathways in Sox9 regulation during embryogenesis.
Campomelic dysplasia with sex reversal is caused by mutations in, or translocations around, one copy of SOX9. It is clear that threshold levels of SOX9 activity are critical for normal function. An understanding of the sex-and tissue-specific regulation of Sox9 is therefore central to a molecular analysis of the sexdetermining and chondrogenic pathways and will provide a basis for searching for regulatory mutations in non-translocation cases of CD for which a structural mutation cannot be found.
As a first step towards understanding the molecular mechanisms of Sox9 regulation, we have characterized the mouse Sox9 promoter and flanking genomic regions in mouse fetal tissues and cultured cells. We find that a 120 bp region close to the transcription start site is associated with maximal promoter activity. This region contributes to, but does not fully account for, the sex-and tissue-specific expression of Sox9 seen in vivo. These findings implicate the involvement of more distal regulatory elements in addition to those in the proximal promoter. 
RESULTS

Identification of the Sox9 transcription start site
Sox9 is strongly expressed in mouse fetal testes and limb bud chondrocytes (3, 8, 9) . In order to delimit the promoter of mouse Sox9, we mapped genomic clones in the Sox9 region ( Fig. 1A ) and determined the transcription start site in both tissues. Primer extension experiments using 11.5 d.p.c. limb bud RNA indicated transcription start sites 363-360 bp upstream from the first ATG, with the strongest band at -361 bp (Fig. 1B) . This position is similar to that in the human SOX9 gene reported previously ( Fig.  2 ; 2). RNase protection assays using a probe spanning the Sox9 promoter confirmed this result. Protected fragments of equal size were detected in both 11.5 d.p.c. limb bud and 13.5 d.p.c. testis RNA (Fig. 1C) . In the ovarian sample, protected bands could be detected at the same position by longer exposure of the autoradiograph (data not shown). Since no intron splicing acceptor consensus sequences are found around this region, we conclude that the gonad-and chondrocyte-specific expression of Sox9 utilizes the same transcription start site and is regulated via the same promoter.
Conserved sequence motifs in the proximal upstream region
Previous studies have shown that the sex-and tissue-specific expression of Sox9 during embryogenesis is conserved among human, mouse and chick (2, 8, 9) . Some evolutionary conservation of important regulatory sequences is therefore expected.
In order to compare the nucleotide sequences upstream of the transcription start site, we isolated human and chick Sox9 genomic DNAs by library screening or PCR. This region was moderately conserved between human and mouse (∼70%; Fig. 2) . Comparison with the chick upstream sequence revealed three conserved elements (two CCAAT boxes and a TATA box), the positions and orientation of which were conserved, suggesting that these elements are important for Sox9 transcription (Fig. 2) . The mouse Sox9 promoter also contains putative GATA and CREB transcription factor binding sites, some of which are conserved (Fig. 2) . We also checked for possible binding sites for SRY, DAX1, SF-1 and WT-1, which function as key regulators in the male or female differentiation pathway of mammalian sex determination (11-15). Of these, only one putative SRY/SOX9 binding site (CACAAT) was found in mouse and human (Fig. 2) . The mouse and human upstream sequences also contain a (CA) n repeat, an additional motif to which SRY protein reportedly binds (16). These observations suggest that DAX-1, SF-1 and WT-1 are not directly involved in Sox9 transcriptional regulation via the proximal promoter and are compatible with the hypotheses that SRY may regulate Sox9 transcription and Sox9 may be transcriptionally autoregulatory.
Open chromatin structure immediately upstream of the Sox9 promoter
It is generally accepted that local chromatin structure affects gene transcription (17). We used DNase I hypersensitivity assays to reveal regions of open chromatin around the Sox9 gene that could interact with positive or negative regulatory factors (Fig. 3) . Assay of genomic fragments between -4 and +1.4 kb from the transcription start site revealed a single DNase I hypersensitive site located in the region immediately upstream of the Sox9 promoter, around the SacI and NheI sites at -193 and -73 bp, respectively (Fig. 3) . The same hypersensitive site was detected in male and female gonadal somatic cells and in 10T1/2 and 3T3 cells which express Sox9, but not in liver cells. These findings implicate the region around the SacI and NheI sites in the Sox9 promoter in accessibility to regulatory factors.
A more extensive search in the regions from -8.6 to -4 kb and from +1.4 to +10 kb revealed no additional DNase I hypersensitive sites (data not shown). We conclude that DNase I hypersensitive sites in the range from -8.6 to +10 kb of the Sox9 gene are restricted to the proximal promoter region. 
Expression levels of Sox9 mRNA in fetal tissues and cell lines
As a basis for interpreting transfection studies using Sox9 reporter constructs, we next examined the expression level of Sox9 mRNA in cells and tissues used in this study. Northern blotting detected two major Sox9 transcripts of 5.5 and 2.3 kb (Fig. 1D) . Sox9 mRNA was found to be expressed at high levels in the limb bud and 10T1/2 cells, which can be induced to chondrogenesis under appropriate culture conditions (S. Wheatley and P. Koopman, unpublished data). Sox9 expression in the male gonad was 2.5-fold higher than that in the ovary, in agreement with published data (9). L-3T3 cells showed a low level of Sox9 expression similar to that in the ovary, while no expression was detectable in liver, even by RT-PCR analysis (data not shown).
Localization of the minimal promoter containing tissue-specific regulatory elements
In order to localize regulatory sequences in the 5′ flanking region of mouse Sox9, transient transfections were performed using various lengths of Sox9 upstream DNA (starting at -6.8 kb to +251 bp and ending at +315 bp relative to the transcription start site) fused to a luciferase reporter. These constructs were co-transfected with a pEF-LacZ reporter. Results were standardized to LacZ expression levels, to control for plasmid copy number in each well, and to luciferase expression levels obtained using a β-actin-luciferase construct, to control for differences in transfection efficiency between cell types.
High levels of luciferase reporter activity were observed in both 10T1/2 and L-3T3 cells using the full-length (-6.8 kb) construct pGL6.8-Luc and progressive deletions to the SacI site in the proximal promoter at -193 bp (pSc-Luc; Fig. 4A ). However, deletion of the region from -193 bp to the NheI site at -73 bp (pNh-Luc) almost completely abolished expression of the reporter construct. A further deletion to the SmaI site at +251 bp in the 5′-untranslated region (5′-UTR) (pSm-Luc) abolished the remaining weak luciferase activity to a level similar to that of the negative control pGL-b-Luc. Similar results were obtained by transfection of these contructs into male and female gonadal somatic cells and liver cells obtained directly from mouse fetal tissues (Fig. 4B) . These data indicate that the region from -193 to -73 bp is essential for maximum Sox9 promoter activity in a range of cell types. This region corresponds well with the DNase I hypersensitive site determined in these cells.
Promoter activities in 10T1/2 cells and testis were consistently higher than those in L-3T3 cells, liver and ovary (Fig. 4) . Deletion of the SacI-NheI (-193 to -73 bp) region abolished this differential. These data suggest that some of the sex and tissue
